| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |